IBM, Swiss Hospital Collaborate on Cancer Diagnostic Test
October 23, 2013 at 06:01 AM EDT
IBM (NYSE: IBM ) scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a